Anti-CXCL4 (PF4) antibody was found to inhibit the percentage of Tregs, while the recombinant CXCL4 protein increased the percentage of Tregs in the CD4+ T in chronic osteomyelitis (50). This evidence concerns the gene CD4 and osteomyelitis.